
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ICL and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ICL and 80,000+ other tickers.
See exactly how ICL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ICL and 80,000+ other tickers.
ICL Group Ltd, a global enterprise specializing in the production of minerals and chemicals, conducts its operations through four distinct business units. The company, which originated as Israel Chemicals Ltd and adopted its current name in May 2020, was founded in 1968 and maintains its headquarters in Tel Aviv, Israel. The Industrial Products segment is responsible for extracting bromine from a byproduct solution generated during potash production, subsequently manufacturing bromine-based compounds. It also produces various grades of potash, salt, magnesium chloride, and magnesia products…

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does ICL Group (ICL) have what it takes?

ICL Group (NYSE: ICL - Get Free Report) and Westaim (OTCMKTS:WEDXF - Get Free Report) are both materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Volatility and Risk ICL Group has a beta of

ICL Group NYSE: ICL reported higher second-quarter 2026 sales, earnings and cash flow, supported by stronger prices for potash, bromine and phosphate products. The company also outlined plans to reorganize its reporting structure in 2027 and introduced a cost-transformation program targeting more than $350 million in annual EBITDA improvements by the end of 2028.

Amundi raised its position in shares of ICL Group Ltd. (NYSE: ICL) by 49.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,115,720 shares of the basic materials company's stock after acquiring an additional 370,457 shares during the period. Amundi

ICL Group Ltd (ICL) Q2 2026 Earnings Call Transcript